Penicillin/Streptomycin/Neomycin solution (~5,000 units penicillin, 5 mg streptomycin and 10 mg neomycin/ml) stabilised, Bioreagent cell culture reagent, sterile filtered
Supplier: Merck
|
Danger
|
M-Clarity™ quality level = MQ200
P4083-100ML
P4083-20ML
SIALP4083-100MLEA
65.4
EUR
SIALP4083-100ML
SIALP4083-20ML
Penicillin/Streptomycin/Neomycin solution (~5,000 units penicillin, 5 mg streptomycin and 10 mg neomycin/ml) stabilised, Bioreagent cell culture reagent, sterile filtered
Penicillin/Streptomycin/Neomycin
Used as a cell culture media supplement to control bacterial contamination
Mode of Action: This product acts in three ways. Penicillin inhibits bacterial cell wall synthesis. Streptomycin inhibits prokaryote protein synthesis by preventing the transition from initiation complex to chain-elongating ribosome, causing miscoding. Neomycin inhibits initiation and elongation during protein synthesis.
Specification Test Results
Appearance (Form) | Liquid |
Appearance (Turbidity) | Clear |
Sterility | Pass |
Endotoxin Level at 10 ml/L | < 0.5 EU/ml |
Cell Line | Hep-2 Human Cells |
Cell Culture Test (percent of control) | > 50 % |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...